Loss of p53 suppresses replication stress-induced DNA damage in ATRX-deficient neuroblastoma
Abstract Genetic aberrations are present in the ATRX gene in older high-risk neuroblastoma (NB) patients with very poor clinical outcomes. Its loss-of-function (LoF) facilitates the alternative lengthening of telomeres (ALT) pathway in tumor cells and is strongly linked to replication stress (RS) an...
Guardado en:
Autores principales: | Jesmin Akter, Yutaka Katai, Parvin Sultana, Hisanori Takenobu, Masayuki Haruta, Ryuichi P. Sugino, Kyosuke Mukae, Shunpei Satoh, Tomoko Wada, Miki Ohira, Kiyohiro Ando, Takehiko Kamijo |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Publishing Group
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/a2daa5a4a53642579e6bb90d160a40c5 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
MYCN amplification and ATRX mutations are incompatible in neuroblastoma
por: Maged Zeineldin, et al.
Publicado: (2020) -
Disruption of ATRX-RNA interactions uncovers roles in ATRX localization and PRC2 function
por: Wenqing Ren, et al.
Publicado: (2020) -
Alternative lengthening of telomeres is not synonymous with mutations in ATRX/DAXX
por: Alexandre de Nonneville, et al.
Publicado: (2021) -
ATRX is a regulator of therapy induced senescence in human cells
por: Marta Kovatcheva, et al.
Publicado: (2017) -
Formal reply to “Alternative lengthening of telomeres is not synonymous with mutations in ATRX/DAXX”
por: Lars Feuerbach
Publicado: (2021)